glp-1 for autoimmune disease Microdosing conditions: what the research actually shows GLP-1 Obesity Drugs May Lower
Description
Patients should consider asking their doctor about fatty liver risk if they have obesity, excess abdominal weight, prediabetes, type 2 diabetes, high triglycerides, high blood pressure, sleep apnea, unexplained liver enzyme elevation, or liver fat found incidentally on ultrasound, CT scan, or MRI
Quote of the Issue Free markets are the most robust mechanism ever devised by humanity for delivering rapid feedback on how decisions turn out
The study focused on two genetic variants that affect the enzyme peptidyl-glycine alpha-amidating monooxygenase (PAM)
Conclusions Compared with TZD, GLP-1RA had better effects on liver fat content, body mass index, and waist circumference in overweight or obese patients with NAFLD or NASH
As one expert put it, a failure to get it right the first time can multiply timelines drastically ( [55] )
